Basics |
INmune Bio Inc. Common stock
|
IPO Date: |
February 4, 2019 |
Sector: |
Healthcare |
Industry: |
Biotechnology |
Market Cap: |
$56.39M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.36 | 3.88%
|
Avg Daily Range (30 D): |
$0.39 | 7.51%
|
Avg Daily Range (90 D): |
$0.32 | 5.07%
|
Institutional Daily Volume |
Avg Daily Volume: |
.24M |
Avg Daily Volume (30 D): |
4.37M |
Avg Daily Volume (90 D): |
1.66M |
Trade Size |
Avg Trade Size (Sh.): |
115 |
Avg Trade Size (Sh.) (30 D): |
128 |
Avg Trade Size (Sh.) (90 D): |
121 |
Institutional Trades |
Total Inst.Trades: |
26 |
Avg Inst. Trade: |
$1.45M |
Avg Inst. Trade (30 D): |
$2M |
Avg Inst. Trade (90 D): |
$1.26M |
Avg Inst. Trade Volume: |
.12M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.74M |
Avg Closing Trade (30 D): |
$2M |
Avg Closing Trade (90 D): |
$1.26M |
Avg Closing Volume: |
185.19K |
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-.43
|
$-.4
|
$-2.11
|
Diluted EPS
|
$-.43
|
$-.4
|
$-2.11
|
Revenue
|
$ .05M
|
$ M
|
$ .01M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -9.74M
|
$ -9.22M
|
$ -42.08M
|
Operating Income / Loss
|
$ -9.91M
|
$ -9.47M
|
$ -42.64M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ .04M
|
$ -.46M
|
$ -.22M
|
PE Ratio
|
|
|
|
|
|
|